Akèy › Limfòm Burkitt › New Jersey › Paterson
Etid klinik pou Limfòm Burkitt nan Paterson, NJ
4 etid pou Limfòm Burkitt ap chèche patisipan nan sit nan ak bò kote Paterson (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Ap rekriteFaz 2
- Saint Joseph's Regional Medical Center, Paterson
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Ap rekriteFaz 2
- Saint Joseph's Regional Medical Center, Paterson
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Ap rekriteFaz 2
- Saint Joseph's Regional Medical Center, Paterson
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Ap rekriteFaz 3
- Saint Joseph's Regional Medical Center, Paterson
Etid Limfòm Burkitt nan lòt vil
- Houston, TX21 etid
- Philadelphia, PA16 etid
- Milwaukee, WI16 etid
- Chicago, IL15 etid
- Cincinnati, OH13 etid
- New York City, NY13 etid
- Atlanta, GA12 etid
- Aurora, CO11 etid
- Seattle, WA11 etid
- Durham, NC10 etid
- Boston, MA10 etid
- Kansas City, MO10 etid
Lòt etid nan Paterson
- Kansè nan tete7 etid
- Leksemi mieloïd egi7 etid
- Kansè Poumon ki pa ti selil6 etid
- Melanom5 etid
- Kansè poumon5 etid
- Kansè (tout kalite)4 etid
- Stenoz valv aòt4 etid
- Ensifizyans kadyak4 etid
- Maladi fwa steatotik3 etid
- Leksemi biphenotipik egi3 etid
- Neoplazmi myeloproliferatif3 etid
- Maladi atè koronè3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.